A Unifying Hypothesis for Scleroderma: Identifying a Target Cell for Scleroderma.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 28, doi. 10.1007/s11926-010-0152-8
- By:
- Publication type:
- Article
Works matching IS 15233774 AND DT 2011 AND VI 13 AND IP 1
Results: 14
1
2
Primary Thrombosis Prophylaxis in Antiphospholipid Antibody-Positive Patients: Where Do We Stand?
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 59, doi. 10.1007/s11926-010-0149-3
- By:
- Publication type:
- Article
3
Biomarkers in the Management of Scleroderma: An Update.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 4, doi. 10.1007/s11926-010-0140-z
- By:
- Publication type:
- Article
4
The Genetics of Scleroderma.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 13, doi. 10.1007/s11926-010-0139-5
- By:
- Publication type:
- Article
5
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 21, doi. 10.1007/s11926-010-0142-x
- By:
- Publication type:
- Article
6
Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody-Positive Patients.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 77, doi. 10.1007/s11926-010-0141-y
- By:
- Publication type:
- Article
7
Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 70, doi. 10.1007/s11926-010-0144-8
- By:
- Publication type:
- Article
8
New Insights into the Biology and Pathobiology of Beta2-Glycoprotein I.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 90, doi. 10.1007/s11926-010-0151-9
- By:
- Publication type:
- Article
9
B-cell-Targeted Therapy for the Fibrotic Complications of Systemic Sclerosis.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 1, doi. 10.1007/s11926-010-0150-x
- By:
- Publication type:
- Article
10
Biomarkers of Scleroderma Lung Disease: Recent Progress.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 44, doi. 10.1007/s11926-010-0143-9
- By:
- Publication type:
- Article
11
The Scleroderma Kidney: Progress in Risk Factors, Therapy, and Prevention.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 37, doi. 10.1007/s11926-010-0145-7
- By:
- Publication type:
- Article
12
Is Testing for Antiphosphatidylethanolamine Antibodies Clinically Useful?
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 81, doi. 10.1007/s11926-010-0147-5
- By:
- Publication type:
- Article
13
Update on Antiphospholipid Syndrome in Children.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 86, doi. 10.1007/s11926-010-0148-4
- By:
- Publication type:
- Article
14
Imatinib and the Treatment of Fibrosis: Recent Trials and Tribulations.
- Published in:
- Current Rheumatology Reports, 2011, v. 13, n. 1, p. 51, doi. 10.1007/s11926-010-0146-6
- By:
- Publication type:
- Article